ÂÜÀòÂÒÂ×

Aditya Kohli, Ph.D., is a Venture Partner with Frazier Healthcare Partners, where he focuses on company creation. Since joining Frazier in 2016, he has co-founded Phathom, HilleVax, and Scout Bio, and helped launch Passage Bio. Currently, Dr. Kohli serves as a Strategic Advisor for Phathom Pharmaceuticals, Chief Operating Officer of HilleVax, and a board member of Scout Bio.

Prior to Frazier, Dr. Kohli was an Engagement Manager with McKinsey & Company, where he served biopharmaceutical companies on business development, research and development, and marketing and sales strategy.

Dr. Kohli received his Ph.D. from the UC Berkeley and UC San Francisco joint graduate program in bioengineering and holds B.S. and M.Eng. degrees in biological engineering from MIT.